Emmy Pharmaceuticals Private Limited
About Emmy Pharmaceuticals Private Limited
Data last updated:
Emmy Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2016PTC040921.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajkumar (Managing Director) and Nilesh Mujawadiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 4 Tulip Row Spring Valley Katara Hills, Bhopal, Madhya Pradesh, India – 462043.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.38 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹64,073 (net margin 1%) and EBITDA of ₹88,064 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 4 Tulip Row Spring Valley Katara Hills, Bhopal, Madhya Pradesh, India – 462043
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emmy Pharmaceuticals Private Limited
The main business activity of Emmy Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emmy Pharmaceuticals Private Limited FY 2025 filings available
Emmy Pharmaceuticals Private Limited reported revenue of ₹66.38 Lakh (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Emmy Pharmaceuticals Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Emmy Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹88,064 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹64,073 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Emmy Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emmy Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emmy Pharmaceuticals Private Limited
Emmy Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Morfik Laboratory Private Limited | ₹66.63 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Meerut, Uttar Pradesh, India |
| Highway Consulting Engineers Private Limited | ₹66.63 Lakh (FY 2025) | •••• | •••• | 115.0% | •••• | Delhi, India |
| Maxnum Healthcare Private Limited | ₹66.6 Lakh (FY 2024) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Allysian Sciences Wellness India Private Limited | ₹66.46 Lakh (FY 2019) | •••• | •••• | -44.0% | •••• | Pune, Maharashtra, India |
| Helpkin Pharmaceuticals Private Limited | ₹66.41 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Emmy Pharmaceuticals Private Limited this company | ₹66.38 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Bhopal, Madhya Pradesh, India |
| JRP Drugs Private Limited | ₹66.31 Lakh (FY 2025) | •••• | •••• | 239.0% | •••• | Raipur, Chhattisgarh, India |
| Zenmac Laboratories Private Limited | ₹66.28 Lakh (FY 2016) | •••• | •••• | -14.0% | •••• | Mandya, Karnataka, India |
| Zorif Pharmaceuticals Private Limited | ₹66.2 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Delhi, India |
| HWLC Pharmaceuticals Private Limited | ₹66.18 Lakh (FY 2024) | •••• | •••• | 31.0% | •••• | Hyderabad, Telangana, India |
| SS Life Science Private Limited | ₹65.92 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Emmy Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Emmy Pharmaceuticals Private Limited
Emmy Pharmaceuticals Private Limited is audited by RAVINDRA SINGH & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAVINDRA SINGH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Emmy Pharmaceuticals Private Limited
Emmy Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar | Managing Director | 10 Jun 2016 | 10 Years 4 Months | Current |
| Nilesh Mujawadiya | Director | 10 Jun 2016 | 10 Years 4 Months | Current |
Ownership and Shareholding of Emmy Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Emmy Pharmaceuticals Private Limited
Emmy Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Emmy Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Emmy Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Emmy Pharmaceuticals Private Limited
Emmy Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Nilesh Mujawadiya was appointed as Director on 10 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Emmy Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emmy Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emmy Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emmy Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emmy Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emmy Pharmaceuticals Private Limited
Emmy Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 June 2016 (10+ years old) and is registered under CIN U51909MP2016PTC040921.
Emmy Pharmaceuticals reported revenue of ₹66.38 Lakh for FY 2025 (down 4% YoY).
Emmy Pharmaceuticals has 2 current directors:
- Rajkumar - Managing Director
- Nilesh Mujawadiya - Director
Emmy Pharmaceuticals reported a net profit of ₹64,073 (net margin 1%) and EBITDA of ₹88,064 (EBITDA margin 1.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Emmy Pharmaceuticals is 13% over three years and 12% over five years. In the latest year (FY 2025) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Emmy Pharmaceuticals is U51909MP2016PTC040921. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emmy Pharmaceuticals was incorporated on 10 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Emmy Pharmaceuticals by revenue are Morfik Laboratory Private Limited, Highway Consulting Engineers Private Limited, Maxnum Healthcare Private Limited, Allysian Sciences Wellness India Private Limited, Helpkin Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Nilesh Mujawadiya was appointed as Director on 10 Jun 2016. Rajkumar was appointed as Managing Director on 10 Jun 2016.
The registered office of Emmy Pharmaceuticals is at D – 4 Tulip Row Spring Valley Katara Hills, Bhopal, Madhya Pradesh, India – 462043.
Emmy Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.